updatesMesoblast limited (NASDAQ:MESO) Given Consensus Rating of...

updatesMesoblast limited (NASDAQ:MESO) Given Consensus Rating of “Buy” by BrokeragesFriday, March 20th, 2020Casey Kowalcyzk Mesoblast limited (NASDAQ:MESO) has received an average rating of “Buy” from the nine brokerages that are presently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $13.83.Receive News & Ratings for Mesoblast DailyEnter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.Several brokerages recently commented on MESO. Zacks Investment Research downgraded Mesoblast from a “buy” rating to a “hold” rating in a report on Tuesday, March 3rd. Maxim Group reiterated a “buy” rating and set a $16.00 target price on shares of Mesoblast in a report on Friday, February 28th. HC Wainwright reiterated a “buy” rating and set a $14.00 target price on shares of Mesoblast in a report on Thursday, February 6th. TheStreet upgraded Mesoblast from a “d” rating to a “c-” rating in a report on Monday, December 2nd. Finally, Dawson James began coverage on Mesoblast in a report on Thursday, December 19th. They set a “buy” rating and a $14.00 target price on the stock.Several large investors have recently made changes to their positions in MESO. M&G Investment Management Ltd. purchased a new stake in shares of Mesoblast during the 4th quarter valued at about $10,440,000. Tobias Financial Advisors Inc. purchased a new stake in Mesoblast during the 4th quarter worth approximately $191,000. Penbrook Management LLC increased its holdings in Mesoblast by 3.9% during the 4th quarter. Penbrook Management LLC now owns 232,100 shares of the company’s stock worth $1,711,000 after purchasing an additional 8,800 shares during the last quarter. Finally, Wilbanks Smith & Thomas Asset Management LLC increased its holdings in Mesoblast by 6.0% during the 4th quarter. Wilbanks Smith & Thomas Asset Management LLC now owns 25,025 shares of the company’s stock worth $184,000 after purchasing an additional 1,425 shares during the last quarter. Institutional investors and hedge funds own 2.07% of the company’s stock.NASDAQ MESO opened at $4.42 on Friday. The firm has a market capitalization of $474.84 million, a P/E ratio of -5.89 and a beta of 1.90. Mesoblast has a 1-year low of $3.52 and a 1-year high of $10.88. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.21 and a quick ratio of 1.21. The business’s 50-day simple moving average is $8.05 and its 200-day simple moving average is $7.10.Mesoblast (NASDAQ:MESO) last released its quarterly earnings data on Wednesday, February 26th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.03). The firm had revenue of $2.21 million during the quarter, compared to analyst estimates of $6.54 million. Mesoblast had a negative net margin of 337.18% and a negative return on equity of 15.48%. On average, equities research analysts expect that Mesoblast will post -0.55 EPS for the current fiscal year.About MesoblastMesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells. The company's products under the Phase III clinical trials include MSC-100-IV for steroid refractory acute graft versus host disease; MPC-150-IM for advanced heart failure; and MPC-06-ID for chronic low back pain due to degenerative disc disease.Read More: No Load FundsCategories: Consensus Rating Articles, MarketsRecent PostsAQR Capital Management LLC Buys 487,887 Shares of McKesson Co. (NYSE:MCK)Essex Private Wealth Management LLC Takes $398,000 Position in Microsoft Co. (NASDAQ:MSFT)Bank of America Corp DE Sells 266,876 Shares of Global Payments Inc (NYSE:GPN)Marathon Oil Co. (NYSE:MRO) CEO Buys $110,000.00 in StockBank of New York Mellon Corp Has $518.56 Million Stake in Eaton Co. PLC (NYSE:ETN)Franklin Resources Inc. Acquires 238 Shares of Invesco QQQ Trust (NASDAQ:QQQ)Microsoft Co. (NASDAQ:MSFT) is KDI Capital Partners LLC’s Largest PositionGladstone Institutional Advisory LLC Grows Position in Apple Inc. (NASDAQ:AAPL)Apple Inc. (NASDAQ:AAPL) Shares Bought by BRITISH COLUMBIA INVESTMENT MANAGEMENT CorpMicrosoft Co. (NASDAQ:MSFT) Shares Sold by Jackson Square Partners LLCBowen Hanes & Co. Inc. Sells 4,277 Shares of Microsoft Co. (NASDAQ:MSFT)J. L. Bainbridge & Co. Inc. Has $75.35 Million Position in Microsoft Co. (NASDAQ:MSFT)Cpwm LLC Purchases 299 Shares of Apple Inc. (NASDAQ:AAPL)Nike (NYSE:NKE) Price Target Cut to $91.00 by Analysts at WedbushJefferies Group LLC Purchases Shares of 10,062 Cathay General Bancorp (NASDAQ:CATY)Home Contact Policies© 2020 Redmond RegisterBack to top